Advertisement

Topics

SMC approves medicines for breast cancer, skin cancer, schizophrenia

06:33 EDT 14 May 2019 | pharmaphorum

The Scottish Medicines Consortium (SMC) has given approvals to Lilly’s breast cancer drug Verzenios, Merck’s Keytruda and Allergan’s schizophrenia drug Reagila – but rejected a drug for sickness during pregnancy based on cost concerns. Eli Lilly’s...

Original Article: SMC approves medicines for breast cancer, skin cancer, schizophrenia

NEXT ARTICLE

More From BioPortfolio on "SMC approves medicines for breast cancer, skin cancer, schizophrenia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Lilly
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...